<?xml version="1.0" encoding="UTF-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" >

	<channel>
		<atom:link rel="self" href="http://www.drugs.com/answers/support-group/tacrine/blog/rss/" type="application/rss+xml" />
		<atom:link rel="next" href="http://www.drugs.com/answers/support-group/tacrine/blog/rss/?page=2" />
		<dc:creator>Drugs.com</dc:creator>
		<dc:language>en</dc:language>
		<dc:rights>Copyright 2013 Drugs.com</dc:rights>
		<link>http://www.drugs.com/answers/support-group/tacrine/blog/</link>
		<title>Tacrine Blog Posts - Drugs.com</title>
		<description>The latest blog posts from the Tacrine support group brought to you by Drugs.com Answers.</description>
		<item>
			<guid isPermaLink="false">b80eb4e0e849af849ea960c43af2b564</guid>
			<link>http://www.drugs.com/news/some-alzheimer-s-conflicting-drugs-34551.html</link>
			<title>Some People With Alzheimer&#039;s Take Conflicting Drugs</title>
			<description><![CDATA[
FRIDAY, Oct. 28 -- Many Alzheimer&#039;s patients who take cholinesterase inhibitors to slow their brain disease also take drugs that counter the effects of those Alzheimer&#039;s medications, a new study says.
Clinical trials have shown that cholinesterase inhibitors such as Aricept (donepezil) have a modest impact on the functional and cognitive decline caused by Alzheimer&#039;s disease, noted the researchers at the Group Health Research Institute in Seattle.
&#34;Cholinesterase inhibitors are today&#039;s primary therapy for slowing Alzheimer&#039;s disease,&#34; study leader Denise Boudreau said in an institute news release.
&#34;Anticholinergic properties are often found in drugs commonly used to treat gastrointestinal disorders, allergies, urinary incontinence, depression and...
			]]></description>
			<category>Tacrine</category>
			<pubDate>Fri, 28 Oct 2011 19:49:33 +0000</pubDate>
			<dc:creator />
		</item>
	</channel>
</rss>